uberization of healthcare. Physicians are starting to "prescribe" smartphoneĀ apps to patients for education, tracking their health or to interface with wearable monitor devices. This physician is using an app created by the American College of Cardiology (ACC) to educate a patient about cardiac function.
New patient portals allow patients immediate access to their health records, including labs,reports and imaging. This is a requirement under Stage 3 Meaningful Use to enable patients to be more involved in their care and to easily share their information with various physicians.Ā 
AliveCor enables a single-lead ECG recordings on a smartphone that can be immediately shared with physician, or scanned by an app to determine if there is an abnormality. These types of devices serve as a basis for mobile healthcare on demand.
The PulsePoint app enables trained CPR responders to get community wide alerts when a 911 center receives a call for sudden cardiac arrest (SCA). The app shows potential first responders near the location on a map of where the patient is located in hopes that they might start CPR prior to the arrival of paramedics. This is an effort to improve CPR response times and SCA survival rates. Pulsepoint, uberization of healthcare, sudden cardiac arrest

Today, in a world of immediate access to information anywhere on the planet using a smartphone, consumers expect more from healthcare, which many experts say will cause a major consumer-driven transformation in care delivery models. Technology has evolved to enable what many are calling the ā€œUberizationā€ of healthcare, where patients will have instant access to healthcare, similar to the Uber app allowing instant access and online tracking for taxi services.

TRU-Vu Monitors has launched a new line of 24-inch HD surgical LCD monitors and touch screens.

Despite numerous major changes looming in the healthcare industry, the 2015 edition of the Great American Physician Survey found that U.S. physicians are still happy in their careers.

Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from PMSS and XANTUS, real-world safety studies of rivaroxaban (Xarelto) in people with non-valvular atrial fibrillation (NVAF). The results found the rates and patterns of major bleeding in routine clinical practice were low (2.89 and 2.1 per 100 person-years, respectively) and generally consistent with those observed in Phase 3 clinical research.

ABSORB STEMI TROFI II trial, ESC 2015, bioresorbable vascular scaffold, BVS, STEMI patients

A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal among patients with an ST-segment elevation myocardial infarction (STEMI), according to results of the ABSORB STEMI TROFI II trial.

Gene transfer therapy to correct an enzyme abnormality involved in myocardial contraction and relaxation did not improve outcomes in heart failure patients with reduced ejection fraction, results of the CUPID 2 study show.

CMS, Medicare Advantage, Value-Based Insurance Design model, VBID, chronic conditions

The Centers for Medicare & Medicaid Services (CMS) announced the creation of the Medicare Advantage Value-Based Insurance Design Model, designed to improve care and reduce costs in Medicare Advantage plans.

Sorin Group announced the start of patient enrollment in its TRIUMPH-CRT clinical trial in Europe.

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now